Foundation Medicine Announces Timing for Fourth Quarter and Year-End 2016 Financial Results and Conference Call

Foundation Medicine, Inc. (NASDAQ:FMI) today announced that financial results for the company's fourth quarter and year ended December 31, 2016 will be released on Wednesday, February 22, 2017. The management team will host a conference call on Wednesday, February 22, 2017, at 4:30 p.m. ET to discuss the company's financial results and recent developments. The call can be accessed by dialing 1-855-420-0652 (domestic) or 1-484-365-2939 (international) five minutes prior to the start of the call and providing the passcode 61272791.

The live, listen-only webcast of the conference call may be accessed by visiting the investors’ section of the company's website at investors.foundationmedicine.com. A replay of the webcast will be available shortly after the conclusion of the call and will be archived on the company's website for two weeks following the call.

About Foundation MedicineFoundation Medicine (NASDAQ:FMI) is a molecular information company dedicated to a transformation in cancer care in which treatment is informed by a deep understanding of the genomic changes that contribute to each patient’s unique cancer. The company offers a full suite of comprehensive genomic profiling assays to identify the molecular alterations in a patient’s cancer and match them with relevant targeted therapies, immunotherapies and clinical trials. Foundation Medicine's molecular information platform aims to improve day-to-day care for patients by serving the needs of clinicians, academic researchers and drug developers to help advance the science of molecular medicine in cancer. For more information, please visit http://www.FoundationMedicine.com or follow Foundation Medicine on Twitter (@FoundationATCG).

Foundation Medicine® is a registered trademark of Foundation Medicine, Inc.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170206005255/en/

Media Contact:Foundation Medicine, Inc.Lee-Ann Murphy, 617-245-3077pr@foundationmedicine.comorInvestor Contact:Kimberly Brown, 617-418-2215ir@foundationmedicine.com

Foundation Medicine, Inc. (NASDAQ:FMI)
Historical Stock Chart
From Mar 2024 to Apr 2024